PharVision Advisers’s MBIA MBI Stock Holding History

PharVision Advisers’s Portfolio MBI Stock Details MBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,375	Closed	-$81.4K	–	422
2025 Q4	$81.4K	Sell	11,375 -17,337	-60%	-$125K	0.04%	662
2025 Q3	$214K	Buy	+28,712	New	+$182K	0.12%	457

Other funds holding MBI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WHCM

Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ValueWorks New York $367M AUM 59.38% 1-Year Est. Return

Hosking Partners London, United Kingdom $2.79B AUM 58.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PharVision Advisers's MBI Position: Q1 2026 in Review

PharVision Advisers sold out of MBIA (MBI) in Q1 2026, closing a stake of 11,375 shares — an estimated $81.4K sold.

PharVision Advisers first reported a position in MBI in Q3 2025 and held it in 2 quarters. The position peaked at $214K in Q3 2025. 133 funds tracked by Wall St. Rank hold MBI as of Q1 2026.

PharVision Advisers reported no remaining MBIA position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 11,375 MBIA shares in Q1 2026, an estimated $81.4K.
PharVision Advisers first reported a position in MBIA in Q3 2025 and held it in 2 quarters.
PharVision Advisers's MBIA position peaked at $214K in Q3 2025.
133 funds tracked by Wall St. Rank held MBIA as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.